Inogen Revenue and Competitors

Location

$73.3M

Total Funding

Estimated Revenue & Valuation

  • Inogen's estimated annual revenue is currently $355.6M per year.(i)
  • Inogen's estimated revenue per employee is $451,244
  • Inogen's total funding is $73.3M.
  • Inogen's current valuation is $699.9M. (January 2022)

Employee Data

  • Inogen has 788 Employees.(i)
  • Inogen grew their employee count by -3% last year.

Inogen's People

NameTitleEmail/Phone
1
VP, Innovation StrategyReveal Email/Phone
2
SVP Investor Relations & Strategic PlanningReveal Email/Phone
3
EVP, General CounselReveal Email/Phone
4
VP, Organizational Effectiveness, Learning, and DevelopmentReveal Email/Phone
5
VP Consumer MarketingReveal Email/Phone
6
VP, B2B Business, US and CanadaReveal Email/Phone
7
SVP, Operations and Supply ChainReveal Email/Phone
8
VP, Marketing and PorfolioReveal Email/Phone
9
VP EngineeringReveal Email/Phone
10
SVP Enterprise Enablement and Patient ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.2M474%N/AN/A
#2
$57.5M2296%N/AN/A
#3
$19670M176108N/AN/A$30.3B
Add Company

What Is Inogen?

Inogen's mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae's Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. We believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. With each step we take to improve our products and service, our customers take another step toward more freedom.

keywords:N/A

$73.3M

Total Funding

788

Number of Employees

$355.6M

Revenue (est)

-3%

Employee Growth %

$699.9M

Valuation

N/A

Accelerator

Inogen News

2022-04-19 - Inogen (INGN) Set to Announce Earnings on Thursday

Inogen (NASDAQ:INGN – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, May 5th.

2022-04-06 - Inogen to Announce First Quarter 2022 Financial Results on ...

Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at:...

2022-03-22 - Inogen Oxygen Concentrator Review – Forbes Health

Inspired by Mae, a grandmother with COPD who complained about the restrictiveness of oxygen therapy—which required switching tanks and carrying...

2014-06-24 - Press Release: Inogen announces FDA clearance of innovative home oxygen concentrator

GOLETA, Calif. — Inogen, Inc. (Nasdaq:INGN) announced today that it has received FDA clearance for an innovative home oxygen concentrator called the Inogen At Home. The Inogen At Home is expected to be the lightest 5 liter per minute continuous flow oxygen concentrator on the market, when it is ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$485.9M17185%N/A
#2
$1026.8M5058N/AN/A
#3
$2870M597910%N/A
#4
$8630M205765%N/A